fibrogen
present
upcoming
investor
conferences
san
francisco
globe
newswire
fibrogen
nasdaq
fgen
today
announced
enrique
conterno
chief
executive
officer
participate
fireside
chats
following
healthcare
conferences
stifel
virtual
healthcare
conference
tuesday
november
pm
eastern
time
jefferies
virtual
london
healthcare
conference
thursday
november
pm
eastern
time
live
audio
webcast
available
events
presentations
section
fibrogen
investor
webpage
https
replay
available
approximately
days
fibrogen
fibrogen
biopharmaceutical
company
committed
discovering
developing
commercializing
pipeline
therapeutics
company
applies
pioneering
expertise
factor
hif
connective
tissue
growth
factor
ctgf
biology
advance
innovative
medicines
treat
unmet
needs
company
currently
developing
commercializing
roxadustat
oral
small
molecule
inhibitor
hif
prolyl
hydroxylase
activity
anemia
associated
chronic
kidney
disease
ckd
roxadustat
also
clinical
development
anemia
associated
myelodysplastic
syndromes
mds
anemia
pamrevlumab
human
monoclonal
antibody
clinical
development
treatment
idiopathic
pulmonary
fibrosis
ipf
locally
advanced
unresectable
pancreatic
cancer
lapc
duchenne
muscular
dystrophy
dmd
coronavirus
information
please
visit
contact
fibrogen
investors
michael
tung
corporate
strategy
investor
relations
mtung
media
jennifer
harrington
